STOCK TITAN

Medline Inc. (MDLN) owner exchanges 500,000 units for Class A stock

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Mozart Holdco, Inc., a 10% owner of Medline Inc. (MDLN), exchanged 500,000 Common Units of Medline Holdings, LP and cancelled 500,000 shares of non-economic Class B common stock for 500,000 shares of Class A common stock on August 6, 2026 under an Exchange Agreement. Following these conversions, it directly holds 787,648 Class A shares, 233,520,656 Common Units and 233,520,656 Class B shares, with Class B shares providing one vote per share and no economic value.

Positive

  • None.

Negative

  • None.
Insider Mozart Holdco, Inc.
Role 10% Owner
Type Security Shares Price Value
Conversion Common Units of Medline Holdings, LP F3, F1 500,000 $0.00 $0.00
Conversion Class A Common Stock F1 500,000 $0.00 $0.00
Other Class B Common Stock F1, F2 500,000 $0.00 $0.00
Holdings After Transaction: Common Units of Medline Holdings, LP — 233,520,656 shares (Direct); Class A Common Stock — 787,648 shares (Direct); Class B Common Stock — 233,520,656 shares (Direct)
Footnotes (3)
  1. F1. Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).
  2. F2. Shares of Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon an exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.
  3. F3. Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.
Common Units exchanged 500,000 units Common Units of Medline Holdings, LP converted into Class A Common Stock on August 6, 2026
Class A Common Stock received 500,000 shares Class A shares issued to Mozart Holdco, Inc. in the exchange on August 6, 2026
Class A shares held after exchange 787,648 shares Mozart Holdco, Inc. direct Class A Common Stock holdings following the reported transactions
Class B shares cancelled 500,000 shares Class B Common Stock automatically cancelled in connection with the August 6, 2026 exchange
Class B shares held after exchange 233,520,656 shares Remaining Class B Common Stock directly owned by Mozart Holdco, Inc. after cancellation
Common Units held after exchange 233,520,656 units Common Units of Medline Holdings, LP remaining after exchanging 500,000 units
Exchange Agreement date December 16, 2025 Date of Exchange Agreement governing exchanges of Common Units into Class A Common Stock
Exchange ratio 1:1 Pursuant to the Exchange Agreement, Common Units may be exchanged for Class A shares on a one-for-one basis
Common Units financial
"Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together"
Common units are the basic ownership stakes in a company, limited partnership, or trust that function like common stock: they give holders a claim on profits and often voting rights. Think of them as the ordinary seats at a table—the most directly affected by the business’s success or failure, so they typically offer higher upside but carry greater risk than preferred claims or creditors, which matters to investors evaluating potential return and safety.
Class B Common Stock financial
"cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock")"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
Section 16(b) regulatory
"Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b)."
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-6(b) regulatory
"Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b)."
Exchange Agreement financial
"pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement")."
A written deal in which two parties agree to swap assets, securities or obligations under set terms—think of it as a formal swap or trade contract. For investors it matters because such agreements can change who owns what, alter a company’s capital structure, affect future cash flows or dilute existing shares, and therefore influence value and risk in a straightforward, contract-driven way.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Mozart Holdco report for MDLN?

Mozart Holdco reported exchanging 500,000 Common Units and cancelling 500,000 Class B shares for 500,000 Class A shares on August 6, 2026, under Medline’s Exchange Agreement. The move restructures its holdings without an open-market purchase or sale.

How many Medline Inc. (MDLN) Class A shares does Mozart Holdco own after this Form 4?

After the reported transactions, Mozart Holdco directly holds 787,648 shares of Medline Inc. Class A common stock. This reflects receipt of 500,000 Class A shares in exchange for Common Units and related Class B shares under the Exchange Agreement.

What happens to Medline (MDLN) Class B Common Stock in this Form 4?

In the exchange, 500,000 shares of Class B Common Stock were automatically cancelled, leaving 233,520,656 Class B shares held. Class B shares have no economic value and provide one vote per share, tied one-for-one to Common Units of Medline Holdings, LP.

What does the Exchange Agreement mean for Medline (MDLN) Common Units?

The Exchange Agreement dated December 16, 2025 lets holders exchange Common Units for Class A common stock on a one-for-one basis, with corresponding Class B shares cancelled. The footnotes state these exchange rights do not expire, providing ongoing flexibility to convert units.

Did the Medline (MDLN) Form 4 involve open-market buying or selling?

No open-market buy or sell is reported. The Form 4 shows a conversion of 500,000 Common Units and related cancellation of Class B shares into 500,000 Class A shares, described as exempt from Section 16(b) in reliance on Rule 16b-6(b).
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mozart Holdco, Inc.

(Last)(First)(Middle)
C/O MEDLINE INC.
3 LAKES DRIVE

(Street)
NORTHFIELD ILLINOIS 60093

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Medline Inc. [ MDLN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
DirectorX10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/06/2026C(1)500,000A$0(1)787,648D
Class B Common Stock08/06/2026J(1)500,000(2)D$0(1)233,520,656(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Units of Medline Holdings, LP(3)08/06/2026C(1)500,000 (3) (3)Class A Common Stock500,000$0(1)233,520,656D
Explanation of Responses:
1. Reflects an exchange of common units of Medline Holdings, LP ("Common Units"), together with the cancellation of the same number of shares of the Issuer's Class B common stock ("Class B Common Stock"), for an equal number of shares of the Issuer's Class A common stock ("Class A Common Stock"), pursuant to the terms of an exchange agreement, dated as of December 16, 2025 (the "Exchange Agreement"). Transactions are exempt from Section 16(b) in reliance on Rule 16b-6(b).
2. Shares of Class B Common Stock have no economic value and have one vote per share. One share of Class B Common Stock is issued for each Common Unit held. Upon an exchange of Common Units for shares of Class A Common Stock, an equivalent number of shares of Class B Common Stock held by such holder will be automatically cancelled.
3. Pursuant to the terms of the Exchange Agreement, holders have the right to exchange their Common Units for shares of Class A Common Stock on a one-for-one basis, subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications. These exchange rights do not expire.
/s/ Eric Orsic, as Attorney-in-Fact for James D. Abrams, Secretary08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)